ROKIT HEALTHCARE to acquire 16.7% stake in Inopia Tech for ₩7.0bn
ROKIT HEALTHCARE Inc. filed on Nov 16, 2026 to acquire 1,400,000 shares of Inopia Tech Co., Ltd. (South Korea) for ₩7.0bn, a 16.7% equity interest, bringing its stake to 100.0%. The acquisition is expected to take place on Mar 31, 2027, and the stated purpose is strengthening business capabilities and creating synergies through acquisition of management control.
Key facts
| Target company | Inopia Tech Co., Ltd. (South Korea) |
|---|---|
| Shares | 1,400,000 shares |
| Deal amount | ₩7.0bn |
| % of equity | 16.7% |
| Stake after | 100.0% |
| Purpose | Strengthening business capabilities and creating synergies through acquisition of management control |
| Expected date | Mar 31, 2027 |
Comparison
| Amount as % of prior-year revenue (calculated) | 26.7% |
|---|---|
| Revenue 2025 | ₩26.2bn |
| Revenue 2024 | ₩13.1bn |
| Revenue 2023 | ₩12.4bn |
Context
By our calculation, the deal amount equals 26.7% of prior-year revenue, and FY2025 revenue was ₩26.2bn. The transaction raises the company's stake in the target from the 16.7% equity interest being acquired to 100.0%.
Related filings
Source: DART (Financial Supervisory Service) · Original filing on DART ↗